Skip to main content

Want a detailed portfolio tracker?

GoodRx (GDRX) Revenue (2019 - 2026)

GoodRx (GDRX) revenue from Mar 31, 2019 to Mar 31, 2026. The TTM GoodRx (GDRX) revenue is $788M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Revenue

Quarterly Revenue

GoodRx (GDRX) Revenue CAGR table

PeriodCAGR
1 Year TTM-1.19%
3 Years TTM+1.78%
5 Years TTM+6.40%
All Time TTM+7.12%

Annual Revenue change of GoodRx (GDRX)

YearRevenueChange
2026$194M-75.65%
2025$797M+0.57%
2024$792M+5.60%
2023$750M-2.12%
2022$767M+2.83%
2021$745M+35.36%
2020$551M+41.85%
2019$388M+55.59%
2018$250MN/A

Comparison GoodRx (GDRX) five years revenue CAGR with competitors

GoodRx (GDRX) five years revenue CAGR is 6.40%.

TickerNamefive years Revenue CAGRUpside
FORAForian Inc70.29%+997.91%
LFMDLifeMD Inc30.45%+375.57%
TALKTalkspace Inc25.62%+300.25%
DOCSDoximity Inc - Class A25.53%+298.77%
PHRPhreesia Inc24.17%+277.54%
PRVAPrivia Health Group Inc22.40%+249.90%
SOPHSOPHiA Genetics SA22.12%+245.45%
TDOCTeladoc Health Inc18.11%+182.89%
OPRXOptimizeRx Corp17.98%+180.88%
SDGRSchrodinger Inc17.45%+172.60%
DRIODarioHealth Corp17.39%+171.72%
VEEVVeeva Systems Inc - Class A16.28%+154.27%
EVHEvolent Health Inc - Class A16.18%+152.71%
TXG10x Genomics Inc - Class A13.93%+117.62%
HQYHealthequity Inc12.94%+102.11%
SLPSimulations Plus Inc10.90%+70.22%
CERTCertara Inc10.67%+66.72%
HCATHealth Catalyst Inc8.67%+35.46%
OMCLOmnicell Inc6.02%-5.89%
TBRGTruBridge Inc5.65%-11.68%
HSTMHealthstream Inc4.79%-25.14%
ZCMDZhongchao Inc - Class A4.43%-30.80%
CCLDCareCloud Inc3.38%-47.18%
CCLDOCareCloud Inc3.38%-47.18%
SYSo-Young International Inc3.30%-48.42%
CTEVMultiPlan Corp - Class A0.80%-87.53%
NRCNational Research Corp0.55%-91.38%